Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Shawn J, Rice"'
Autor:
Shawn J Rice, Chandra P Belani
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0260988 (2021)
Blood-based biomarkers including systemic inflammation (SI) indicators or circulating factors (cytokines, chemokines, or growth factors) are associated with a poor prognosis for lung cancer patients. Collectively these biomarkers can predict the immu
Externí odkaz:
https://doaj.org/article/73f5cf2c0e2d4cfcaea1c952bc51f472
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0217657 (2019)
Lung cancer is among the common and deadly cancers. Although the treatment options for late-stage cancer patients have continued to increase in numbers, the overall survival rates for these patients have not shown significant improvement. This highli
Externí odkaz:
https://doaj.org/article/a7ad9fd966d24fb9bb72eeadce9a3546
Autor:
Shawn J. Rice, Chandra P. Belani
Publikováno v:
ProteomicsREFERENCES. 22(17)
Traditional data-independent acquisition (DIA) workflows employ off-column fractionation with data-dependent acquisition (DDA) to generate spectral libraries for data extraction. Recent advances have led to the establishment of library-independent ap
Autor:
Madhusmita Behera, Victoria Hyland, Shawn J. Rice, Suresh S. Ramalingam, Paul A. Bunn, Chandra P. Belani
Publikováno v:
Journal of Thoracic Oncology
In the summer of 2019, there was a rise in clusters of adolescents and young adults in the United States reporting to emergency departments with acute respiratory distress related to use of e-cigarette (electronic cigarette) or vaping. The number of
Autor:
Chandra P. Belani, Rongling Wu, Xin Liu, Libo Jiang, Mengmeng Sang, Shawn J. Rice, Claudia Gragnoli
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 18, Iss, Pp 45-51 (2020)
Computational and Structural Biotechnology Journal
Computational and Structural Biotechnology Journal
Intratumoral heterogeneity (ITH) has been regarded as a key cause of the failure and resistance of cancer therapy, but how it behaves and functions remains unclear. Advances in single-cell analysis have facilitated the collection of a massive amount
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0118210 (2015)
V-Raf Murine Sarcoma Viral Oncogene Homolog B (BRAF) mutated lung cancer is relatively aggressive and is resistant to currently available therapies. In a recent phase II study for patients with BRAF-V600E non-small cell lung cancer (NSCLC), BRAF V600
Externí odkaz:
https://doaj.org/article/afdc1f6d364a4a11836d9ae9ebf03bf8
Autor:
Myung-Ju Ahn, Marina Chiara Garassino, Lynette L.S. Teo, Egbert F. Smit, Murry W. Wynes, Soon Ho Yoon, Graham W. Warren, Young Tae Kim, Francesco De Cobelli, Joachim G.J.V. Aerts, Chandra P. Belani, Shu-Yuan Xiao, Abdul Rahman Jazieh, John B. A. G. Haanen, Solange Peters, Giulia Veronesi, Anne Marie C. Dingemans, Madhusmita Behera, Alex A. Adjei, Shawn J. Rice, Ross A. Soo, Suresh S. Ramalingam, Shun Lu, Giorgio V. Scagliotti
Publikováno v:
Journal of Thoracic Oncology
Journal of thoracic oncology, vol. 15, no. 7, pp. 1119-1136
Journal of Thoracic Oncology, 15(7), 1119-1136. International Association for the Study of Lung Cancer
Journal of Thoracic Oncology, 15(7), 1119-1136. ELSEVIER SCIENCE INC
Journal of thoracic oncology, vol. 15, no. 7, pp. 1119-1136
Journal of Thoracic Oncology, 15(7), 1119-1136. International Association for the Study of Lung Cancer
Journal of Thoracic Oncology, 15(7), 1119-1136. ELSEVIER SCIENCE INC
The global coronavirus disease 2019 pandemic continues to escalate at a rapid pace inundating medical facilities and creating substantial challenges globally. The risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patie
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 131
Objectives High levels of circulating interleukin-6 (IL-6) are associated with a poor prognosis in many types of cancer including non-small cell lung cancer (NSCLC). While the inflammatory cytokine can stimulate the immune system and promote tumor gr
Autor:
Junjia Zhu, Jianhong Zhang, Chandra P. Belani, Yaxian Kong, Hong Zheng, Xin Liu, Monika Joshi, Shawn J. Rice, Liuluan Zhu, Matthias Wagman
Publikováno v:
Oncotarget
// Hong Zheng 1, * , Xin Liu 1, * , Jianhong Zhang 1 , Shawn J. Rice 1 , Matthias Wagman 1 , Yaxian Kong 2 , Liuluan Zhu 2 , Junjia Zhu 1 , Monika Joshi 1 , Chandra P. Belani 1 1 Penn State Hershey Cancer Institute, Penn State College of Medicine, He
Publikováno v:
PM&R. 8:990-996
Lung cancer remains a challenging disease with high morbidity and mortality despite targeted therapy. Symptom burden related to cancer impairs quality of life and functional status in patients with lung cancer and in survivors. Pulmonary rehabilitati